Saul A Rosenberg

Medical oncologist, Lymphoma specialist, Hematologist

Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Lymphoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Memorial Sloan-Kettering Cancer Center (1958) NY

Medical Education: Case Western Reserve University School of Dentistry (1953) OH

Residency: Peter Bent Brigham Hospital (1961) MA

Residency: Peter Bent Brigham Hospital (1957) MA

Board Certification: Medical Oncology, American Board of Internal Medicine (1973)

Board Certification: Internal Medicine, American Board of Internal Medicine (1961)

Internship: University Hospitals of Cleveland (1954) OH

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., & Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. BLOOD, 122(6), 981-987.

Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial
Advani, R. H., Hoppe, R. T., Baer, D., Mason, J., Warnke, R., & Horning, S. J. (2013). Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial. ANNALS OF ONCOLOGY, 24(4), 1044-1048.

Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials
Koontz, M. Z., Horning, S. J., Balise, R., Greenberg, P. L., Rosenberg, S. A., & Advani, R. H. (2013). Risk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma: The Stanford University Experience Over Three Generations of Clinical Trials. JOURNAL OF CLINICAL ONCOLOGY, 31(5), 592-598.

STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE
Advani, R. H., Hoppe, R. T., Maeda, L. S., Baer, D. M., Mason, J., & Horning, S. J. (2011). STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(5), 1374-1379.

Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue
Nguyen, T. T., Warnke, R. A., Seo, K., Rosenberg, S. A., & Arber, D. A. (2010). Rare presentation of classical Hodgkin lymphoma with a clonal T-cell receptor gene rearrangement in the tissue. LEUKEMIA & LYMPHOMA, 51(7), 1356-1359.

Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease
Kohrt, H., Johannsen, A., Hoppe, R., Horning, S. J., Rosenberg, S. A., & Lee, P. P. (2009). Dynamic CD8 T-Cell Responses to Tumor-Associated Epstein-Barr Virus Antigens in Patients With Epstein-Barr Virus-Negative Hodgkin's Disease. ONCOLOGY RESEARCH, 18(5-6), 287-292.

Lymphography: A Great Advance, Abandoned
Rosenberg, S. A. (2008). Lymphography: A Great Advance, Abandoned. JOURNAL OF CLINICAL ONCOLOGY, 26(35), 5662-5663.

Follicular lymphoma revisited
Rosenberg, S. A. (2008). Follicular lymphoma revisited. JOURNAL OF CLINICAL ONCOLOGY, 26(4), 515-516.

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
Advani, R., Maeda, L., Lavori, P., Quon, A., Hoppe, R., & Horning, S. J. (2007). Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease. JOURNAL OF CLINICAL ONCOLOGY, 25(25), 3902-3907.

Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges
Brody, J. D., Advani, R., Shin, L. K., Bingham, D. B., & Rosenberg, S. A. (2006). Splenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease: diagnostic and therapeutic challenges. ANNALS OF HEMATOLOGY, 85(11), 817-820.

Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy
Advani, R., Rosenberg, S. A., & Horning, S. J. (2004). Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy. JOURNAL OF CLINICAL ONCOLOGY, 22(8), 1454-1459.

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial
Horning, S. J., Hoppe, R. T., Breslin, S., Bartlett, N. L., Brown, B. W., & Rosenberg, S. A. (2002). Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. JOURNAL OF CLINICAL ONCOLOGY, 20(3), 630-637.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., & Blume, K. G. (2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. BLOOD, 97(2), 404-409.

Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support
Advani, R., Warnke, R., & Rosenberg, S. (1999). Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support. ANNALS OF ONCOLOGY, 10(10), 1207-1209.

Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation
Horning, S. J., Hoppe, R. T., Mason, J., Brown, B. W., Hancock, S. L., & Rosenberg, S. A. (1997). Stanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease: Subtotal lymphoid irradiation versus vinblastine, methotrexate, and bleomycin chemotherapy and regional irradiation. JOURNAL OF CLINICAL ONCOLOGY, 15(5), 1736-1744.

Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
Yuen, A. R., Rosenberg, S. A., Hoppe, R. T., HALPERN, J. D., & Horning, S. J. (1997). Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease. BLOOD, 89(3), 814-822.

The management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture
Rosenberg, S. A. (1996). The management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture. ANNALS OF ONCOLOGY, 7(6), 555-560.

Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update
Horning, S. J., Rosenberg, S. A., & Hoppe, R. T. (1996). Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update. ANNALS OF ONCOLOGY, 7, 105-108.

BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT
Bartlett, N. L., Rosenberg, S. A., Hoppe, R. T., Hancock, S. L., & Horning, S. J. (1995). BRIEF CHEMOTHERAPY, STANFORD-V, AND ADJUVANT RADIOTHERAPY FOR BULKY OR ADVANCED-STAGE HODGKINS-DISEASE - A PRELIMINARY-REPORT. JOURNAL OF CLINICAL ONCOLOGY, 13(5), 1080-1088.

CLASSIFICATION OF LYMPHOID NEOPLASMS
Rosenberg, S. A. (1994). CLASSIFICATION OF LYMPHOID NEOPLASMS. BLOOD, 84(5), 1359-1360.

Modern combined modality management of Hodgkin's disease.
Rosenberg, S. A. (1994). Modern combined modality management of Hodgkin's disease. Current opinion in oncology, 6(5), 470-472.

The treatment of Hodgkin's disease.
Rosenberg, S. A. (1994). The treatment of Hodgkin's disease. Annals of oncology , 5, 17-21.

THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE
Horning, S. J., Ang, P. T., Hoppe, R. T., & Rosenberg, S. A. (1992). THE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE, ALKERAN AND VINBLASTINE (PAVE) AND RADIOTHERAPY FOR LOCALLY EXTENSIVE AND ADVANCED STAGE HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 3(9), 747-754.

REDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE
Rosenberg, S. A. (1992). REDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE. EUROPEAN JOURNAL OF CANCER, 28A(8-9), 1379-1380.

THE CONTINUING CHALLENGE OF HODGKINS-DISEASE
Rosenberg, S. A. (1991). THE CONTINUING CHALLENGE OF HODGKINS-DISEASE. ANNALS OF ONCOLOGY, 2, 29-31.

CEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA
Chao, N. J., Rosenberg, S. A., & Horning, S. J. (1990). CEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA. BLOOD, 76(7), 1293-1298.

HODGKINS-DISEASE - CHALLENGES FOR THE FUTURE
Rosenberg, S. A. (1989). HODGKINS-DISEASE - CHALLENGES FOR THE FUTURE. CANCER RESEARCH, 49(4), 767-769.

PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE
LEIBENHAUT, M. H., Hoppe, R. T., Efron, B., Halpern, J., Nelsen, T., & Rosenberg, S. A. (1989). PROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 7(1), 81-91.

Current Stanford clinical trials for Hodgkin's disease.
Hoppe, R. T., Horning, S. J., Hancock, S. L., & Rosenberg, S. A. (1989). Current Stanford clinical trials for Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer, 117, 182-190.

VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE
Horning, S. J., Hoppe, R. T., Hancock, S. L., & Rosenberg, S. A. (1988). VINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE. JOURNAL OF CLINICAL ONCOLOGY, 6(12), 1822-1831.

INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS
Hancock, S. L., Hoppe, R. T., Horning, S. J., & Rosenberg, S. A. (1988). INTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS. ANNALS OF INTERNAL MEDICINE, 109(3), 183-189.

EXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY
Rosenberg, S. A. (1988). EXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY. JOURNAL OF CLINICAL ONCOLOGY, 6(4), 574-575.